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Abstract 
Background: The GRK4 and EMILIN1 genes have been suggested to be involved in the de-
velopment of hypertension. However, the results have been inconsistent. In this study, a 
meta-analysis was performed to clarify the associations of polymorphisms in the GRK4 and 
EMILIN1 genes with hypertension risk.  
Methods: Published literature from PubMed and Embase databases were retrieved. Pooled 
odds ratios (ORs) with 95% confidence intervals (CIs) were calculated using fixed- or ran-
dom-effects model.  
Results: Five studies for polymorphisms in the GRK4 gene and five studies for polymorphisms 
in the EMILIN1 gene were identified. The results suggested that rs1801058 polymorphism in 
the GRK4 gene was inversely associated with hypertension among East Asians (TT vs. CC: 
OR=0.39, 95%CI 0.28-0.55) and positively associated with hypertension among Europeans 
(TT vs. CC: OR= 2.38, 95%CI 1.38-4.10). Rs2960306 polymorphism in the GRK4 gene was 
significantly associated with hypertension among Europeans (TT vs. GG: OR=1.92, 95%CI 
1.13-3.27). The significant associations were also observed for rs2011616 and rs2304682 
polymorphisms in the EMILIN1 gene among Japanese (rs2011616: AA vs. GG: OR=0.38, 
95%CI 0.18-0.82; rs2304682: GG vs. CC: OR=0.37, 95%CI 0.17-0.81) but not among Chinese.  
Conclusions: This meta-analysis suggested that rs1801058 polymorphism in the GRK4 gene 
was associated with hypertension in East Asians and Europeans. The significant association 
was also found for rs2960306 polymorphism in the GRK4 gene among Europeans. In addition, 
there  were  significant  associations  of  rs2011616  and  rs2304682  polymorphisms  in  the 
EMILIN1gene with hypertension among Japanese. 
Key words: Hypertension, GRK4, EMILIN1, Polymorphism, Meta-analysis. 
Introduction 
Hypertension is associated with stroke and car-
diovascular disease which are major causes of global 
health burden [1]. Epidemiological studies have sug-
gested that environmental factors (e.g. excess alcohol 
consumption, increased salt intake, and less physical 
activity) could increase the risk of hypertension [2]. 
However, many studies supported that hypertension 
is a complex disease resulting from the interactions of 
genes  and  environmental  factors  [3].  Twin  studies 
have shown that approximately 50% of blood pres-
Ivyspring  
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sure  variation  was  determined  by  genetics  [4]. 
Therefore,  the  identification  of  new  susceptibility 
genes  would  help  further  elucidate  the  underlying 
molecular mechanisms of hypertension. 
G protein-coupled receptor kinase 4 (GRK4) has 
been  involved  in  the  development  of  hypertension 
since it plays an important role in the desensitization 
of the dopamine receptor 1(D1) [5]. Dopamine con-
tributes to sodium balance by facilitating natriuresis 
through  activation  of  D1  on  the  renal  proximal  tu-
bules [6]. Therefore, polymorphisms in the GRK4 gene 
might contribute to sodium retention and hyperten-
sion through inactivation of the D1 receptor. A486V 
(rs1801058), R65L (rs2960306) and A142V (rs1024323) 
polymorphisms  were  the  most  frequently  studied 
ones. However, the results have been inconsistent.  
The elastin microfibril interfacer-1(EMILIN1) is 
implicated in stabilise elastin and related microfibrils, 
and affects vessel compliance and the blood pressure 
(BP). Evidences have suggested that EMILIN1 inhibits 
TGF-β  signaling  by  specifically  binding  to  the 
proTGF-β precursor and plays a key role in BP ho-
meostasis  [7].  To  date,  three  polymorphisms 
(rs2011616, rs2304682 and rs3754734) in the EMILIN1 
gene have been reported to be associated with BP or 
hypertension  in  different  ethnic  populations.  How-
ever, the results also have been conflicting. 
Therefore, in this study, we performed the me-
ta-analysis  to  clarify  the  associations  of  polymor-
phisms in the GRK4 and EMILIN1 genes with hyper-
tension risk across different ethnic populations. 
Materials and methods 
Literature and search strategy 
We searched the literature databases including 
PubMed and Embase. The search strategy to identify 
all possible studies involved the use of the following 
key words: (G-protein coupled receptor Kinase-4 or 
GRK4  or  the  elastin  microfibril  interfacer-1  or 
EMILIN1) and (variant or variation or polymorphism) 
and  hypertension.  All  related  studies  published  in 
English  and  Chinese  languages  were  included.  The 
reference  lists  of  retrieved  articles  were 
hand-searched.  If  more  than  one  article  were  pub-
lished using the same data, only the study with largest 
sample size was included. The literature search was 
updated on September 13, 2011. 
Inclusion criteria and data extraction 
The studies included in the meta-analysis must 
meet all the following inclusion criteria: (1) evaluated 
the  association  of  polymorphism  in  the  GRK4  or 
EMILIN1  gene  with  hypertension;  (2)  used 
case-control or cohort design; (3) provided sufficient 
data for calculation of odds ratio (OR) with 95% con-
fidence interval (CI). The following information was 
extracted from each study: (1) name of the first author; 
(2)  year  of  publication;  (3)  country;  (4)  gender  fre-
quency  and  mean  age  of  subjects  in  hypertensive 
cases and controls; (5) sample size of cases and con-
trols; (6) genotype distribution in cases and controls; 
and  (7)  P  value  for  Hardy–Weinberg  equilibrium 
(HWE)  test  in  controls.  The  two  authors  inde-
pendently  assessed  the  articles  for  compliance  with 
the  inclusion/exclusion  criteria,  resolved  disagree-
ments and reached a consistent decision. 
Statistical analysis 
The associations of polymorphisms in the GRK4 
or EMILIN1 gene with hypertension were estimated 
by  calculating  pooled  ORs  and  95%  CIs  under  a 
co-dominant,  a  dominant  and  a  recessive  genetic 
model,  respectively.  The  significance  of  pooled  OR 
was determined by Z test (p<0.05 was considered sta-
tistically significant). Q test was performed to evalu-
ate  to  the  between-study  heterogeneity.  A  random- 
(DerSimonian-Laird  method  [8])  or  fixed-  (Man-
tel-Haenszel method  [9]) effects model was used to 
calculate pooled OR in the presence (p<=0.10) or ab-
sence  (p>0.10)  of  heterogeneity,  respectively.  Sub-
group  analysis  by  ethnicity  was  performed.  Begg’s 
funnel plot, a scatter plot of effect against a measure of 
study size, was generated as a visual aid to detect bias 
or systematic heterogeneity [10]. Publication bias was 
assessed by Egger’s test [11] (p<0.05 was considered 
statistically significant). Data analysis was performed 
using STATA version 11 (StataCorp LP, College Sta-
tion,  Texas,  USA).  To  correct  for  multiple  compari-
sons,  the  false  discovery  rate  (FDR)  approach  was 
used [12]. FDR analysis (0.05 as criteria) was applied 
for  four  genetic  models,  six  polymorphisms,  12 
groups  for  three  polymorphisms  in  the  GRK4  gene 
and 7 groups for three  polymorphisms in  EMILIN1 
gene  simultaneously  (number  of  tests: 
4×4×3+4×7=76). 
Results 
Characteristics of the studies 
The literature search identified a total of 41 po-
tentially  relevant  papers.  Of  these,  27  papers  were 
excluded because of obvious irrelevance by reading 
the  titles  and  abstracts.  In  addition,  three  reviews 
[13-15], one duplicated publication [16], and one pa-
per [17] which assessed the associations of polymor-
phisms with salt-sensitive hypertension was exclud-
ed. It should be noted that the paper by Shen et al. [23] Int. J. Med. Sci. 2012, 9 
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contained two studies. Finally, five studies for poly-
morphisms in the GRK4 gene [18-22] and five studies 
for polymorphisms in the EMILIN1 gene [23-26] met 
the inclusion criteria and  were included in the me-
ta-analysis. The characteristics of the included studies 
were listed in Table 1. 
Meta-analysis results 
Regarding GRK4 gene, five studies (1000 cases 
and 1059 controls) for rs1801058 polymorphism, five 
studies (1012 cases and 1119 controls) for  rs2960306 
polymorphism, and five studies (1018 cases and 1004 
controls) for rs1024323 polymorphism were included 
in the meta-analysis. The results indicated no signifi-
cant association for all three polymorphisms with the 
risk of hypertension under all genetic models (Table 
2).  Further  subgroup  analysis  by  ethnicity  showed 
that  rs1801058  polymorphism  was  inversely  associ-
ated with hypertension among East Asians (Chinese) 
(TT  vs.  CC:  OR=0.39,  95%CI  0.28-0.55;  CT  vs.  CC: 
OR=0.55,  95%CI  0.40-0.75;  TT+CT  vs.  CC:  OR=0.48, 
95%CI  0.36-0.64;  TT  vs.  CT+CC:  OR=0.57,  95%CI 
0.43-0.76), but positively associated with hypertension 
among  Europeans  (TT  vs.  CC:  OR=  2.38,  95%CI 
1.38-4.10;  CT  vs.  CC:  OR=1.66,  95%CI  1.08-2.55; 
TT+CT  vs.  CC:  OR=1.82,  95%CI  1.21-2.74;  TT  vs. 
CT+CC: OR=1.70, 95%CI 1.07-2.70). Rs2960306 poly-
morphism  was  significantly  associated  with  hyper-
tension  among  Europeans  (TT  vs.  GG:  OR=1.92, 
95%CI  1.13-3.27;  TT  vs.  GT+GG:  OR=1.94,  95%CI 
1.19-3.18) (Table 2).  
 
 
Table 1. Characteristics of the studies included in the meta-analysis. 
Study  Country  Ethnicity  Gender (M/F)  Age, mean±SD, 
years 
Sample Size  Polymorphisms  Definitions (SBP/DBP, 
mmHg) 
Cases  Controls  Cases  Controls  Cases  Controls  Hypertension  Controls 
GRK4 gene                       
Bengra, 2002  Italy  European  NA  NA  NA  NA  60  60  rs2960306; 
rsl024323; 
rs1801058 
≥140/90  <140/90  
Williams, 2004  Ghana  African  NA  NA  NA  NA  126  51  rs2960306; 
rsl024323; 
rs1801058 
≥160/95 a  <140/90 
Speirs, 2004  Australia  
and UK 
European  67/101  178/134  54±12  47±11  168  312  rs2960306; 
rsl024323; 
rs1801058 
≥140/90  <130/90 
Wang, 2006  China  East 
Asian 
262/241  257/233  53.6±9.3  53.5±9.2  503  490  rs2960306; 
rsl024323; 
rs1801058 
≥160/100  <140/90 
Martinez Can-
tarin,2010 
US  African  100/73  109/130  40±6  36±8  173  239  rs2960306; 
rsl024323; 
rs1801058 
≥140/90 b  <130/80 
EMILIN1 gene                       
Shen,2009  China  East 
Asian 
262/241  257/233  53.6 ± 9.3  53.5 ± 9.2  503  490  rs2011616; 
rs2304682; 
rs3754734 
≥160/100 b  <140/90 
Shen,2009  China  East 
Asian 
393/421  401/378  54.5 ± 
10.7 
53.5 ± 9.7  814  779  rs2011616; 
rs3754734 
≥160/100 b  <140/90 
Shimodaira,2010 Japan  East 
Asian 
193/94  157/96  49.8 ± 6.8  51.1 ± 9.9  287  253  rs2011616; 
rs2304682 
≥160/100  <130/85 
Oh,2011  Singapore East 
Asian 
268/199  157/318  49.4±11.9  47.3±8.7  467  475  rs2011616  ≥140/90 c  <134/84 
Mi,2011  China  East 
Asian 
NA  NA  52.5±9.4  49.0±10.3  201  202  rs2011616; 
rs2304682; 
rs3754734 
≥140/90  <140/90 
NA, not available. 
a or who had been previously diagnosed as hypertensive. 
b or currently taking antihypertensive medications. 
c or mean 24-h ambulatory blood pressure ≥135/85mmHg. 
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Table 2. Pooled ORs and 95%CIs of the associations between polymorphisms in the GRK4 gene and hypertension risk. 
Contrasts  No. of studies 
(cases/ con-
trols) 
Homogeneous 
co-dominant model 
Heterogeneous 
co-dominant model 
Dominant model  Recessive model 
OR  95% CI  P H  OR  95% CI  P H  OR  95% CI  P H  OR  95% CI  P H 
rs1801058                            
All  5 (1000/1059)  1.26  0.42-3.80  0.000  0.95  0.57-1.58  0.001  1.01  0.54-1.86  0.000  1.15  0.56-2.35  0.002 
European  2 (205/308)  2.38  1.38-4.10  0.624  1.66  1.08-2.55  0.759  1.82  1.21-2.74  0.636  1.70  1.07-2.70  0.629 
African  2 (292/261)  1.06  0.32-3.48  0.282  0.69  0.46-1.04  0.354  0.72  0.49-1.07  0.195  1.06  0.35-3.83  0.317 
East Asian (Chinese)  1 (503/490)  0.39  0.28-0.55  -  0.55  0.40-0.75  -  0.48  0.36-0.64  -  0.57  0.43-0.76  - 
rs2960306                           
All  5 (1012/1119)  1.22  0.86-1.73  0.239  0.91  0.74-1.11  0.955  0.94  0.77-1.15  0.688  1.23  0.90-1.68  0.178 
European  2 (220/372)  1.92  1.13-3.27  0.795  0.98  0.68-1.41  0.792  1.13  0.80-1.60  0.650  1.94  1.19-3.18  0.863 
African  2 (289/257)  0.95  0.56-1.60  0.666  0.97  0.64-1.45  0.944  0.96  0.65-1.41  0.907  0.96  0.61-1.50  0.572 
East Asian (Chinese)  1 (503/490)  0.62  0.22-1.76  -  0.83  0.61-1.13  -  0.81  0.60-1.10  -  0.65  0.23-1.83  - 
rs1024323                           
All  5 (1018/1004)  0.98  0.70-1.36  0.185  0.92  0.75-1.13  0.487  0.91  0.75-1.11  0.292  0.99  0.75-1.29  0.376 
European  2 (228/249)  1.50  0.84-2.66  0.856  1.09  0.74-1.61  0.606  1.17  0.81-1.69  0.771  1.43  0.84-2.43  0.692 
African  2 (287/265)  0.98  0.57-1.68  0.227  1.00  0.60-1.66  0.191  0.99  0.60-1.61  0.179  0.98  0.68-1.40  0.751 
East Asian (Chinese)  1 (503/490)  0.57  0.30-1.10  -  0.82  0.63-1.08  -  0.79  0.61-1.03  -  0.61  0.32-1.16  - 
P H, P value for heterogeneity based on Q test. 
 
Table 3. Pooled ORs and 95%CIs of the associations between polymorphisms in the EMILIN1 gene and hypertension risk. 
Contrasts  No. of studies 
(cases/controls) 
Homogeneous co-dominant model Heterogeneous 
co-dominant model 
Dominant model  Recessive model 
OR  95% CI  P H  OR  95% CI  P H  OR  95% CI  P H       
rs2011616                           
All  5 (2262/2189)  0.89  0.70-1.12  0.105  0.89  0.70-1.12  0.015  0.88  0.69-1.12  0.006  0.92  0.74-1.16  0.258 
Chinese  4 (1975/1936)  0.97  0.76-1.24  0.478  0.94  0.73-1.21  0.020  0.95  0.75-1.21  0.020  1.00  0.79-1.27  0.777 
Japanese  1 (287/253)  0.38  0.18-0.82  -  0.67  0.46-0.97  -  0.61  0.43-0.87  -  0.44  0.21-0.93  - 
                           
rs2304682                           
All  3 (991/945)  1.05  0.39-2.81  0.001  1.06  0.68-1.67  0.006  1.06  0.62-1.81  0.000  1.00  0.45-2.22  0.010 
Chinese  2 (704/692)  1.66  0.64-4.34  0.032  1.24  0.99-1.55  0.124  1.37  0.86-2.17  0.047  1.42  0.66-3.05  0.075 
Japanese  1 (287/253)  0.37  0.17-0.81  -  0.67  0.46-0.97  -  0.61  0.43-0.87  -  0.42  0.19-0.92  - 
rs3754734                           
All (Chinese)  3 (1485/1468)  1.09  0.86-1.39  0.485  1.21  0.83-1.77  0.006  1.19  0.84-1.68  0.009  0.99  0.79-1.25  0.970 
P H, P value for heterogeneity based on Q test. 
 
 
Regarding  EMILIN1  gene,  five  studies  (2262 
cases and 2189 controls) for rs2011616 polymorphism, 
three  studies  (991  cases  and  945  controls)  for 
rs2304682  polymorphism,  and  three  studies  (1485 
cases and 1468 controls) for rs3754734 polymorphism 
were included in the meta-analysis. Overall, there was 
no  significant  association  between  three  polymor-
phisms and hypertension among East Asians (Table 
3). In the stratified analysis, the significant association 
was  observed  for  rs2011616  and  rs2304682  among 
Japanese  (rs2011616  AA  vs.  GG:  OR=0.38,  95%CI 
0.18-0.82;  GA  vs.  GG:  OR=0.67,  95%CI  0.46-0.97; 
AA+GA  vs.  GG:  OR=0.61,  95%CI  0.43-0.87;  AA  vs. 
GA+GG: OR=0.44, 95%CI 0.21-0.93. rs2304682 GG vs. 
CC: OR=0.37, 95%CI 0.17-0.81; CG vs. CC: OR=0.67, 
95CI  0.46-0.97;  CG+GG  vs.  CC:  OR=0.61,  95%CI 
0.43-0.87; GG vs. CG+CC: OR=0.42, 95%CI 0.19-0.92) 
but not among Chinese (Table 3). 
The  significant  associations  for  the  polymor-
phisms above remained even after FDR was applied, 
although they disappeared in some genetic models of 
the polymorphisms. 
Discussion 
To our knowledge, this is the first meta-analysis 
which comprehensively assessed the  associations  of Int. J. Med. Sci. 2012, 9 
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polymorphisms in the GRK4 and EMILIN1genes with 
hypertension  risk.  To  date,  several  studies  have  in-
vestigated  the  associations  among  different  ethnic 
populations.  However,  the  findings  have  been  con-
flicting, with results of increased, decreased, or no risk 
of hypertension for the same polymorphism. The dis-
crepant results might be due to many reasons such as 
the differences in statistical power, recruitment pro-
cedures of the study population, and the genetic and 
environmental  backgrounds.  The  present  me-
ta-analysis indicated that rs1801058 polymorphism in 
the GRK4 gene was inversely associated with hyper-
tension among East Asians, but positively associated 
with  hypertension  among  Europeans.  In  addition, 
there was a significant association between rs2960306 
in the GRK4 gene and hypertension among Europe-
ans.  We  also  observed  significant  associations  of 
rs2011616  and  rs2304682  polymorphisms  in  the 
EMILIN1 gene with hypertension among Japanese. 
It is possible that the effect sizes of genetic fac-
tors  predisposing  to  human  diseases  are  different 
across  various  ethnic  populations  [27].  Indeed,  the 
distributions  of  most  polymorphisms  are  much  dif-
ferent  in  the  various  ethnic  populations.  Taking 
rs1801058  polymorphism  in  the  GRK4  gene  for  an 
example, the frequency of T allele is about 0.398 in 
European population; while it is about 0.494 in Chi-
nese, 0.529 in Japanese, and 0.097 in African (HapMap 
data). Moreover, the exposure to environmental fac-
tors  might  be  also  different  across  different  ethnic 
populations. Therefore, the subgroup analysis based 
on  ethnicity  was  performed.  The  results  suggested 
this  polymorphism  was  inversely  associated  with 
hypertension in East Asians, but positively associated 
with hypertension in Europeans. However, no statis-
tically  significant  association  was  observed  in  Afri-
cans. The effect of ethnic differences was also demon-
strated for rs2960306 polymorphism, with the signif-
icant  association  only  in  Europeans.  However,  the 
effect of rs2011616 and rs2304682 polymorphisms in 
the  EMILIN1gene  on  hypertension  among  Japanese 
could not be explained by ethnic differences since the 
genetic  backgrounds  are  very  similar  between  Chi-
nese and Japanese populations. Therefore, it is possi-
ble  that  the  effect  differences  were  due  to  different 
environmental  backgrounds  or  gene-environment 
interactions.  
The  mechanisms  of  how  the  rs1801058  and 
rs2960306  polymorphisms  in  the  GRK4  gene  and 
rs2011616  and  rs2304682  polymorphisms  in  the 
EMILIN1 gene  influence  hypertension  susceptibility 
among  East  Asians  or  Europeans  are  still  unclear. 
GRK4  is  expressed  in  the  nephron  segments  of  the 
kidney, where sodium transport is regulated by do-
pamine and angiotensin II [28]. The 4p16.3, where the 
GRK4  gene  located,  has  been  indicated  to  be  im-
portant  in  the  development  of  hypertension  [29]. 
Other genes, such as the α-adducin and D5 receptor 
genes, which close to 4p arm, have also been linked to 
hypertension.  Those  three  polymorphisms  in  the 
GRK4 gene are associated with a constitutive increase 
in kinase activity in proximal tubule cells from hu-
mans  with  essential  hypertension  [30].  Increases  in 
BP,  peripheral  vascular  resistance  and  reduces  in 
vessel  size  have  been  observed  among  EMILIN1 
knockout  animals  [7].  It  has  been  shown  that 
EMILIN1 links TGF-β maturation to BP homeostasis. 
In  addition,  EMILIN1  could  bind  specially  to  the 
proTGF-β  precursor  and  prevent  its  maturation  by 
furin convertases  in  the extracellular space, thereby 
inhibiting TGF-β signaling [7].  
The current meta-analysis has some advantages 
compared  to  other  individual  studies;  however,  it 
does have some limitations. First, the  meta-analysis 
was based primarily on unadjusted ORs and CIs be-
cause of the unavailability of adjusted estimates from 
the primary publications, and then the confounding 
factors  might  influence  the  precision  of  effect  esti-
mates.  Second,  the  effects  of  gene-gene/ 
gene-environment interactions were not addressed in 
this  meta-analysis.  Third,  the  statistical  power  was 
limited in the subgroup analysis based on ethnicity. 
Therefore, the conclusions should be interpreted with 
caution.  Fourth,  more  than  one  polymorphism  in 
GRK4 or EMILIN1gene was investigated among each 
study; however, the haplotype analysis was not per-
formed among most studies, which impeded us for 
the further meta-analysis. 
 In summary, this meta-analysis suggested that 
rs1801058 polymorphism in the GRK4 gene was asso-
ciated with hypertension in East Asians and Europe-
ans; rs2960306 polymorphism in the GRK4 gene was 
significantly  associated  with  hypertension  among 
Europeans. In addition, there was a significant asso-
ciation of rs2011616 and rs2304682 polymorphisms in 
the EMILIN1gene with hypertension among Japanese. 
However,  further  studies  are  needed  to  investigate 
the role of polymorphisms in the GRK4 and EMILIN1 
genes in the pathogenesis of hypertension. 
Potential publication bias 
No  publication  bias  was  detected  for  all  six 
polymorphisms by Egger’s test (all P>0.05). 
Acknowledgements  
This  study  was  supported  by  Independent  In-
novation  Foundation  of  Shandong  University 
(2010GN046)  and  the  Foundation  for  Outstanding Int. J. Med. Sci. 2012, 9 
 
http://www.medsci.org 
279 
Young  Scientist  in  Shandong  Province 
(BS2011YY026). 
Competing Interests 
The  authors  have  declared  that  no  competing 
interest exists. 
References 
1.  Lawes  CM,  Vander  Hoorn  S,  Rodgers  A.  Global  burden  of 
blood-pressure-related disease, 2001. Lancet 2008; 371 (9623): 1513-1518. 
2.  Whelton PK, He J, Appel LJ, et al. Primary prevention of hypertension: 
clinical and public health advisory from The National High Blood Pres-
sure Education Program. JAMA 2002; 288(15): 1882-1888. 
3.  Williams  SS.  Advances  in  genetic  hypertension.  Curr  Opin  Pediatr 
2007;19(2):192-198. 
4.  Luft FC. Twins in cardiovascular genetic research. Hypertension 2001; 
37(2 Part 2): 350-356. 
5.  Jose PA, Eisner GM, Felder RA. Role of dopamine receptors in the kid-
ney in the regulation of blood pressure. Curr Opin Nephrol Hypertens 
2002; 11(1):87-92. 
6.  Jose PA, Eisner GM,  Felder RA. Dopamine and the kidney: a role in 
hypertension? Curr Opin Nephrol Hypertens 2003; 12(2):189-194. 
7.  Zacchigna L, Vecchione C, Notte A, et al. Emilin1 links TGF-beta matu-
ration to blood pressure homeostasis. Cell 2006; 124(5):929-942. 
8.  DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin 
Trials 1986; 7(3):177-188. 
9.  Mantel N, Haenszel W. Statistical aspects of the analysis of data from 
retrospective studies of disease. J Natl Cancer Inst 1959; 22(4):719-748. 
10.  Begg CB, Mazumdar M. Operating characteristics of a rank correlation 
test for publication bias. Biometrics 1994; 50(4):1088-1101. 
11.  Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis de-
tected by a simple, graphical test. BMJ 1997; 315(7109):629-634. 
12.  Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical 
and powerful approach to multiple testing. J Royal Stat Soc B 1995; 57: 
289–300. 
13.  Thompson  MD,  Cole  DE,  Jose  PA.  Pharmacogenomics  of  G  pro-
tein-coupled  receptor  signaling:  insights  from  health  and  disease. 
Methods Mol Biol 2008; 448:77-107. 
14.  Zeng C, Sanada H, Watanabe H, Eisner GM, Felder RA, Jose PA. Func-
tional genomics of the dopaminergic  system in hypertension. Physiol 
Genomics 2004; 19(3):233-246.  
15.  Felder  RA,  Jose  PA.  Mechanisms  of disease:  the  role  of  GRK4  in  the 
etiology  of  essential  hypertension  and  salt  sensitivity.  Nat  Clin  Pract 
Nephrol 2006; 2(11):637-650. 
16.  Gu  D,  Su  S,  Ge  D,  et  al.  Association  study  with  33  single-nucleotide 
polymorphisms in 11 candidate genes for hypertension in Chinese. Hy-
pertension. 2006; 47(6):1147-1154. 
17.  Sanada  H,  Yatabe  J,  Midorikawa  S,  et  al.  Single-nucleotide  polymor-
phisms  for  diagnosis  of  salt-sensitive  hypertension.  Clin  Chem  2006; 
52(3):352-360.  
18.  Bengra C, Mifflin TE, Khripin Y, et al. Genotyping of essential hyperten-
sion single-nucleotide polymorphisms by a homogeneous PCR method 
with  universal  energy  transfer  primers.  Clin  Chem 
2002;48(12):2131-2140. 
19.  Speirs HJ, Katyk K, Kumar NN, et al. Association of G-protein-coupled 
receptor kinase 4 haplotypes, but not HSD3B1 or PTP1B polymorphisms, 
with essential hypertension. J Hypertens 2004;22(5):931-936. 
20.  Williams SM, Ritchie MD, Phillips JA3rd, et al. Multilocus analysis of 
hypertension: a hierarchical approach. Hum Hered 2004; 57(1):28-38. 
21.  Wang Y, Li B, Zhao W, et al. Association study of G protein-coupled 
receptor kinase 4 gene variants with essential hypertension in northern 
Han Chinese. Ann Hum Genet 2006; 70(Pt 6):778-783. 
22.  Martinez Cantarin MP, Ertel A, Deloach S, et al. Variants in genes in-
volved in functional pathways associated with hypertension in African 
Americans. Clin Transl Sci 2010; 3(6):279-286.  
23.  Shen C, Lu X, Li Y, et al. Emilin1 gene and essential hypertension: a 
two-stage association study in northern Han Chinese population. BMC 
Med Genet 2009; 10:118. 
24.  Shimodaira  M,  Nakayama  T,  Sato  N,  et  al.  Association  study  of  the 
elastin microfibril interfacer 1 (EMILIN1) gene in essential hypertension. 
Am J Hypertens 2010; 23(5):547-555.  
25.  Oh  VM,  Chua  BM,  Heng  CK,  et  al.  Association  of  intronic  sin-
gle-nucleotide polymorphisms in the EMILIN1 gene with essential hy-
pertension  in  a  Chinese  population.  J  Hum  Hypertens  2011;  doi: 
10.1038/jhh.2011.68.  
26.  Mi DQ, Wang BY, Sun H, et al. Association of EMILIN1 gene polymor-
phism with essential hypertension in Mongolian. Chin J Med Genet 2011; 
28(2):160-164.  
27.  Pan Z, Trikalinos TA, Kavvoura FK, et al. Local literature bias in genetic 
epidemiology:  an  empirical  evaluation  of  the  Chinese  literature.  PloS 
Med 2005; 2(12):e334. 
28.  Felder  RA,  Jose  PA.  Mechanisms  of disease:  the  role  of  GRK4  in  the 
etiology  of  essential  hypertension  and  salt  sensitivity.  Nat  Clin  Pract 
Nephrol 2006; 2(11):637-650. 
29.  Allayee H, de Bruin TW, Michelle Dominguez K, et al. Genome scan for 
blood pressure in Dutch dyslipidemic families reveals linkage to a locus 
on chromosome 4p. Hypertension 2001; 38(4):773-778. 
30.  Felder RA, Sanada H, Xu J, et al. G protein-coupled receptor kinase 4 
gene variants in human essential hypertension. Proc Natl Acad Sci USA 
2002;99(6):3872-3877. 